Irritable Bowel Syndrome Demographics: A Middle Eastern Multinational Cross-sectional Study

Pezhman Alavinejad 1 2, Parvin Mousavi Ghanavati 1, Mohamed Alboraie 2 3, Mohamed Emara 2 4, Siamak Baghaee 1, Bulent Baran 2 5, Naser Ebrahimi Daryani 6, Farnaz Farsi 7, Eskandar Hajiani 1, Seyed Jalal Hashemi 1, Elena Lak 8, Yasaman Taheri 1, Abhijit Dangi 9

Affiliations

01 April 2022

-

doi: 10.34172/mejdd.2022.276

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is the most frequent functional gastrointestinal (GI) disorder. In this study, we aimed to evaluate the different aspects of IBS among Middle Eastern residents. METHODS: During the study period, patients attending gastroenterology clinics of nine tertiary referral centers in four Middle Eastern couturiers (Iran, Egypt, Kuwait, and Turkey) were evaluated by Rome IV diagnostic criteria, and those who fulfilled the diagnostic criteria of IBS were asked to fill in a questionnaire covering different demographics and clinical aspects. RESULTS: Overall, during a 6-month period, 509 patients with IBS were included. 41.3% of the participants were male (210 patients), and 37.4% of them had academic education. 50% of the participants were Caucasian, and 34% were Arab, and originally, they were citizens of 18 countries. 77.4% of the participants were residents of subtropical areas, while 22.2% were living in temperate regions. The average age of the participants during the first presentation in subtropical and temperate areas were 38.4 ± 12.19 and 38.06 ± 12.18 years, respectively (P = 0.726). The most common subtypes of IBS in subtropical areas were unclassified (IBS-U, 44.4%), constipation dominant (IBS-C, 27.6%), mixed pattern (IBS-M, 21%), and diarrhea dominant (IBS-D, 6.8%) in descending order while in temperate areas the most common subtypes were IBS-U (43.3%), and IBS-D (22.1%), respectively (P < 0.001). Besides abdominal pain, the most common symptom of patients in each region was bloating (62.2% and 68.1%, respectively, P = 0.246). The rate of depression and anxiety were significantly higher among the residents of temperate areas in comparison with subtropical regions (41.6% vs. 16.5% and 80.5% vs. 58.4%, respectively, P < 0.001). CONCLUSION: Although the average age of IBS presentation is the same in subtropical and temperate areas, it seems that in temperate areas, the rate of IBS-D is more prevalent than in subtropical regions. The rate of anxiety and depression are significantly higher among those who searched social media and the internet to get information about their problems.

Keywords: Bloating; Irritable bowel syndrome; Subtropical areas; Temperate regions.

Conflict of interest statement

CONFLICT OF INTEREST The authors declare no conflict of interest related to this work.

Figures

Fig. 1:

Fig. 1:

Fig. 2:

Fig. 2:

Fig. 3:

Fig. 3:

Fig. 4:

Fig. 4:

Fig. 5:

Fig. 5:

Fig. 6:

Fig. 6:

Similar articles

Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan.

Kanazawa M, Miwa H, Nakagawa A, Kosako M, Akiho H, Fukudo S.Biopsychosoc Med. 2016 Jun 4;10:19. doi: 10.1186/s13030-016-0070-8. eCollection 2016.PMID: 27274765 Free PMC article.

Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.

Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B.World J Gastroenterol. 2015 Jul 14;21(26):8103-9. doi: 10.3748/wjg.v21.i26.8103.PMID: 26185382 Free PMC article.

Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.

Su AM, Shih W, Presson AP, Chang L.Neurogastroenterol Motil. 2014 Jan;26(1):36-45. doi: 10.1111/nmo.12220. Epub 2013 Aug 29.PMID: 23991913 Free PMC article.

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea.

Colomier E, Algera J, Melchior C.Front Pharmacol. 2021 Feb 18;11:629026. doi: 10.3389/fphar.2020.629026. eCollection 2020.PMID: 33679391 Free PMC article. Review.

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. doi: 10.1002/14651858.CD003960.pub3.PMID: 17943807 Review.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91. doi: 10.1053/j.gastro.2005.11.061. - DOI - PubMed
  2.  
    1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123(6):2108–31. doi: 10.1053/gast.2002.37095. - DOI - PubMed
  3.  
    1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–21. doi: 10.1016/j.cgh.2012.02.029. - DOI - PubMed
  4.  
    1. Dean BB, Aguilar D, Barghout V, Kahler KH, Frech F, Groves D. et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care. 2005;11(1 Suppl):S17–26. - PubMed
  5.  
    1. Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15(1):35. doi: 10.1186/s12955-017-0611-2. - DOI - PMC - PubMed
  6.  
    1. Fass R, Longstreth GF, Pimentel M, Fullerton S, Russak SM, Chiou CF. et al. Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med. 2001;161(17):2081–8. doi: 10.1001/archinte.161.17.2081. - DOI - PubMed
  7.  
    1. Dalrymple J, Bullock I. Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance. BMJ. 2008;336(7643):556–8. doi: 10.1136/bmj.39484.712616.AD. - DOI - PMC - PubMed
  8.  
    1. Bommelaer G, Poynard T, Le Pen C, Gaudin AF, Maurel F, Priol G. et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol. 2004;28(6-7 Pt 1):554–61. doi: 10.1016/s0399-8320(04)95011-7. - DOI - PubMed
  9.  
    1. Palsson OS, Whitehead WE, van Tilburg MA, Chang L, Chey W, Crowell MD. et al. Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology. 2016;150(6):1481–91. doi: 10.1053/j.gastro.2016.02.014. - DOI - PubMed
  10.  
    1. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome Proposed strategies to control expenditures. Pharmacoeconomics. 2000;17(4):331–8. doi: 10.2165/00019053-200017040-00003. - DOI - PubMed
  11.  
    1. Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm. 2013;19(9):755–64. doi: 10.18553/jmcp.2013.19.9.755. - DOI - PubMed
  12.  
    1. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis The lancet Gastroenterology & hepatology. 2020. Oct 1;5(10):908–17. doi: 10.1016/S2468-1253(20)30217-X. - DOI - PubMed
  13.  
    1. Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA. et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66(6):1075–82. doi: 10.1136/gutjnl-2015-311240. - DOI - PubMed
  14.  
    1. Whorwell PJ. Behavioral therapy for IBS. Nat Clin Pract Gastroenterol Hepatol. 2009;6(3):148–9. doi: 10.1038/ncpgasthep1361. - DOI - PubMed
  15.  
    1. Choung RS, Talley NJ. Food allergy and intolerance in IBS. Gastroenterol Hepatol (N Y) 2006;2(10):756–60. - PMC - PubMed
  16.  
    1. Lea R, Whorwell PJ. Psychological influences on the irritable bowel syndrome. Minerva Med. 2004;95(5):443–50. - PubMed
  17.  
    1. Huerta-Franco MR, Vargas-Luna M, Tienda P, Delgadillo-Holtfort I, Balleza-Ordaz M, Flores-Hernandez C. Effects of occupational stress on the gastrointestinal tract. World J Gastrointest Pathophysiol. 2013;4(4):108–18. doi: 10.4291/wjgp.v4.i4.108. - DOI - PMC - PubMed
  18.  
    1. Adger WN. Climate change, human well-being and insecurity. New Political Econ. 2010;15(2):275–92. doi: 10.1080/13563460903290912. - DOI
  19.  
    1. Endo Y, Shoji T, Fukudo S. Epidemiology of irritable bowel syndrome. Ann Gastroenterol. 2015;28(2):158–9. - PMC - PubMed
  20.  
    1. Fontaine SS, Novarro AJ, Kohl KD. Environmental temperature alters the digestive performance and gut microbiota of a terrestrial amphibian. J Exp Biol. 2018;221(Pt 20):jeb187559. doi: 10.1242/jeb.187559. - DOI - PubMed
  21.  
    1. Bestion E, Jacob S, Zinger L, Di Gesu L, Richard M, White J. et al. Climate warming reduces gut microbiota diversity in a vertebrate ectotherm. Nat Ecol Evol. 2017;1(6):161. doi: 10.1038/s41559-017-0161. - DOI - PubMed
  22.  
    1. Pagán R, García-Gonzalo D. Influence of environmental factors on bacterial biofilm formation in the food industry: a review. Postdoc J. 2015;3(6):3–13.
  23.  
    1. Maier RM, Pepper IL. Bacterial growth. In: Pepper IL, Gerba CP, Gentry TJ, eds. Environmental Microbiology. 3rd ed. San Diego: Academic Press; 2015. p. 37-56. 10.1016/b978-0-12-394626-3.00003-x - DOI
  24.  
    1. Moxley E, Puerta-Fernández E, Gómez EJ, Gonzalez JM. Influence of abiotic factors temperature and water content on bacterial 2-chlorophenol biodegradation in soils. Front Environ Sci. 2019;7:41. doi: 10.3389/fenvs.2019.00041. - DOI
  25.  
    1. Senghor B, Sokhna C, Ruimy R, Lagier JC. Gut microbiota diversity according to dietary habits and geographical provenance. Hum Microb J. 2018;7-8:1–9. doi: 10.1016/j.humic.2018.01.001. - DOI
  26.  
    1. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R. et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr. 2010;51(1):77–84. doi: 10.1097/MPG.0b013e3181d1b11e. - DOI - PubMed
  27.  
    1. Lin D, Wang R, Luo J, Ren F, Gu Z, Zhao Y. et al. The core and distinction of the gut microbiota in Chinese populations across geography and ethnicity. Microorganisms. 2020;8(10):1579. doi: 10.3390/microorganisms8101579. - DOI - PMC - PubMed
  28.  
    1. Ghoshal UC, Gwee KA. Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol. 2017;14(7):435–41. doi: 10.1038/nrgastro.2017.37. - DOI - PubMed
  29.  
    1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–21. doi: 10.1016/j.cgh.2012.02.029. - DOI - PubMed
  30.  
    1. Hassanzadeh Keshteli A, Dehestani B, Daghaghzadeh H, Adibi P. Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults. Ann Gastroenterol. 2015;28(2):253–8. - PMC - PubMed
  31.  
    1. Alharbi SH. Epidemiology of irritable bowel syndrome in Saudi Arabia. Am J Med Med Sci. 2018;8(1):7–13. doi: 10.5923/j.ajmms.20180801.02. - DOI
  32.  
    1. Abdulmajeed A, Rabab MA, Sliem HA, Hebatallah NE. Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan Afr Med J. 2011;9:5. doi: 10.4314/pamj.v9i1.71177. - DOI - PMC - PubMed
  33.  
    1. Elhosseiny D, Mahmoud NE, Manzour AF. Factors associated with irritable bowel syndrome among medical students at Ain Shams University. J Egypt Public Health Assoc. 2019;94(1):23. doi: 10.1186/s42506-019-0023-8. - DOI - PMC - PubMed
  34.  
    1. Ringel Y, Williams RE, Kalilani L, Cook SF. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7(1):68–72. doi: 10.1016/j.cgh.2008.07.008. - DOI - PubMed
  35.  
    1. Jiang X, Locke GR, 3rd 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008;57(6):756–63. doi: 10.1136/gut.2007.142810. - DOI - PMC - PubMed
  36.  
    1. Chang L, Lee OY, Naliboff B, Schmulson M, Mayer EA. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96(12):3341–7. doi: 10.1111/j.1572-0241.2001.05336.x. - DOI - PubMed
  37.  
    1. Azpiroz F, Malagelada JR. Abdominal bloating. Gastroenterology. 2005;129(3):1060–78. doi: 10.1053/j.gastro.2005.06.062. - DOI - PubMed
  38.  
    1. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol. 2008;103(5):1241–8. doi: 10.1111/j.1572-0241.2007.01755.x. - DOI - PubMed
  39.  
    1. Kanazawa M, Miwa H, Nakagawa A, Kosako M, Akiho H, Fukudo S. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. Biopsychosoc Med. 2016;10:19. doi: 10.1186/s13030-016-0070-8. - DOI - PMC - PubMed
  40.  
    1. Alavinejad P, Hashemi SJ, Hajiani E, Roomi A, Shahriari A, Karimi Moghaddam E. Low dose mesalazine plus bismuth regimen and symptoms of irritable bowel syndrome in patients with bloating: a quasi-experimental study. Jundishapur J Chronic Dis Care. 2016;5(4):e35043. doi: 10.17795/jjcdc-35043. - DOI
  41.  
    1. Alavinejad P. The boundary between IBD and IBS: irritable colitis. Gastroenterol Hepatol Open Access. 2014;1(3):00014. doi: 10.15406/ghoa.2014.01.00014. - DOI
  42.  
    1. Rhee PL. [Definition and epidemiology of irritable bowel syndrome] Korean J Gastroenterol. 2006;47(2):94–100. - PubMed
  43.  
    1. Iakovenko EP, Agafonova NA, Pokhal'skaia O, Kolganova AV, Nazarbekova RS, Ivanov AN. et al. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea] Klin Med (Mosk) 2008;86(10):47–52. - PubMed
  44.  
    1. De Choudhury M, Morris MR, White RW. Seeking and sharing health information online: comparing search engines and social media. In: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. New York, NY: Association for Computing Machinery (ACM); 2014. p. 1365-76. 10.1145/2556288.2557214 - DOI
  45.  
    1. Lin WY, Zhang X, Song H, Omori K. Health information seeking in the Web 20 age: trust in social media, uncertainty reduction, and self-disclosure. Comput Human Behav. 2016;56:289–94. doi: 10.1016/j.chb.2015.11.055. - DOI
  46.  
    1. Iftikhar R, Abaalkhail B. Health-seeking influence reflected by online health-related messages received on social media: cross-sectional survey. J Med Internet Res. 2017;19(11):e382. doi: 10.2196/jmir.5989. - DOI - PMC - PubMed
  47.  
    1. Winker MA, Flanagin A, Chi-Lum B, White J, Andrews K, Kennett RL. et al. Guidelines for medical and health information sites on the internet: principles governing AMA web sites American Medical Association. JAMA. 2000;283(12):1600–6. doi: 10.1001/jama.283.12.1600. - DOI - PubMed
  48.  
    1. Impicciatore P, Pandolfini C, Casella N, Bonati M. Reliability of health information for the public on the World Wide Web: systematic survey of advice on managing fever in children at home. BMJ. 1997;314(7098):1875–9. doi: 10.1136/bmj.314.7098.1875. - DOI - PMC - PubMed
  49.  
    1. Silberg WM, Lundberg GD, Musacchio RA. Assessing, controlling, and assuring the quality of medical information on the Internet: caveant lector et viewor--let the reader and viewer beware. JAMA. 1997;277(15):1244–5. doi: 10.1001/jama.1997.03540390074039. - DOI - PubMed

Page Navigation